by editor | Sep 21, 2012 | Clinicians, Participants, Researchers
Humble hero or hidden villain? The ongoing story of aspirin’s powers The evidence for taking aspirin daily as a cancer preventative is not considered sufficiently robust. Andrew Tonkin, Monash University The humble aspirin has a remarkable history dating...
by editor | Aug 15, 2012 | Participants
ASPREE’s Lynn O’Neill’s features in Bendigo’s positive and active ageing newsletter ‘Zoom’ Many central Victorian ASPREE participants will have met Lynn at study visits. She came from Melbourne to the area in late 2010, a move she hasn’t regretted. Lynn...
by editor | Jul 10, 2012 | Clinicians, Participants
500th participant from the region enrols in aspirin trial Over 150 people marked a recruitment milestone – the 500th participant from the ACT to enrol in the ASPREE study – at a morning tea in Canberra today. ASPREE, the largest primary prevention...
by editor | Mar 22, 2012 | Clinicians, Participants, Researchers
Underscores the need for a large clinical trial in older adults, says ASPREE Principal Investigator ANNOUNCEMENT Research findings by Rothwell et al, (two published in ‘The Lancet’ and one in ‘The Lancet Oncology’) to hit the media today are suggesting that...
by editor | Jan 13, 2012 | Clinicians, Participants, Researchers
ASPREE leads quest for answers in older adults, says Investigator Above: Professor Mark Nelson, a chief investigator to the ASPREE trial in Tasmania, said Australia is already studying the benefit versus risk of daily low-dose aspirin use in healthy...
Recent Comments